Leal Therapeutics Inc
Leal Therapeutics Inc. is a biotechnology company focused on developing innovative therapeutics for disorders of the central nervous system (CNS). The company is advancing its lead programs, LTX-002 and LTX-001, towards first-in-human trials, aiming to address unmet medical needs in CNS disorders.
Leadership & Board
Key Executives
- Founder
- Asa Abeliovich
- Current Number of Employees
- 35
- Current LinkedIn Followers
- 5,903
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $75M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $30M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Employee Trend
Leal Therapeutics Inc had 35 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
35Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Leal Therapeutics Inc had 5,903 followers as of October 12, 2026. The number of followers increased by 6 (0.10%) week-over-week.
5,903Latest Followers Count
6(0.10%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 17, 2026 | Series A | $30.00M | ― |
| Aug 14, 2025 | Investment | $45.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Eli Lilly and Company | Series A |
| OrbiMed | Series A |
| Newpath Partners | Series A |
| Euclidean Capital | Series A |
| Chugai Venture Fund | Series A |
| Alexandria Venture Investments | Series A |
| PhiFund | Series A |
| OrbiMed | Investment |
Similar Companies
A snapshot of private companies similar to Leal Therapeutics Inc, helping you discover and navigate related company profiles.
Related News and Analysis
